• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 SOLITAIRE; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 SOLITAIRE; CATHETER, THROMBUS RETRIEVER Back to Search Results
Model Number NV UNK SOLITAIRE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 02/03/2022
Event Type  Death  
Event Description
Liu, h., zhang, y., fan, h., wen, c., (2022) risk factors and functional outcomes with early neurological deterioration after mechanical thrombectomy for acute large vessel occlusion stroke, journal of neurological surgery, 84, doi https://doi.Org/ 10.1055/a-1762-0167.Medtronic literature review found report of patient complications in association with solitaire stent.The study analyzed data from 79 patients with large vessel occlusion who received mechanical thrombectomy (mt).Authors aimed to investigate the incidence, risk factors, and functional outcomes with early neurological deterioration (end) after mt, and therefore aim to provide evidence for more precise clinical practice.Of the 79 patients, the median age was 63 years, 52 were males and 27 were females.Patients with occluded arteries were: 40 at middle cerebral artery (mca) (50.6%), 20 at internal carotid artery (ica) (25.3%), and 19 at vertebral basilar artery (ba) (24.1%).The article does not state any technical issues during use of the solitaire.14 patients died after mt.There were 19 patients with functional outcome after 90 days mrs >2 (75.9%).Of the patients with poor functional outcome, 32 experienced end with two or more national institutes of health stroke scale (nihss) increase.The incidence of end after mt was 32/79 (40.5%), of which 12 had ischemic stroke progression, 11 had encephaledema, and nine had symptomatic cerebral hemorrhage.Among the 32 end cases, three deteriorated within 24 hours, four within 24 to 48 hours, and 25 within 48 to 72 hours.There were 19 patients with functional outcome after 90 days mrs >2 (75.9%).  12 patients experienced unsuccessful reperfusion (mtici 2b).
 
Manufacturer Narrative
G2: citation: authors: liu, h., zhang, y., fan, h., wen, c.,.Risk factors and functional outcomes with early neurological deterioration after mechanical thrombectomy for acute large vessel occlusion stroke.Journal of neurological surgery 84 2022.Doi: 10.1055/a-1762-0167 earliest date of publication used for date of event no unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLITAIRE
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18486266
MDR Text Key332601255
Report Number2029214-2024-00083
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNV UNK SOLITAIRE
Device Catalogue NumberNV UNK SOLITAIRE
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age63 YR
Patient SexMale
-
-